These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 987200)

  • 21. Dual actions of lysergic acid diethylamide tartrate (LSD), 2-bromo-D-lysergic acid diethylamide bitartrate (BOL) and methysergide on dorsal root potentials evoked by stimulation of raphe nuclei.
    Larson AA; Chinn C; Proudfit HK; Anderson EG
    J Pharmacol Exp Ther; 1981 Apr; 217(1):99-104. PubMed ID: 6110778
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlation of toxicity & pyretogenic activity of lysergamides with van der Waals volume.
    Bindal MC; Singh P; Gupta SP
    Indian J Biochem Biophys; 1981 Apr; 18(2):164-5. PubMed ID: 7309090
    [No Abstract]   [Full Text] [Related]  

  • 23. [Azabenzomorphane and related compounds. IV. Synthesis of 2-substituted-4-quinoline-acetic acid derivatives. (Studies on the syntheses of heterocyclic compounds. CXVI)].
    Kametani T; Hiiragi M; Kigasawa K
    Yakugaku Zasshi; 1965 Sep; 85(9):836-9. PubMed ID: 5893172
    [No Abstract]   [Full Text] [Related]  

  • 24. [Synthesis of (+)-lysergic acid diethylamide tartrate].
    Zhang CZ; Yang JH; Zhou J
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1984 Feb; 6(1):70-2. PubMed ID: 6238704
    [No Abstract]   [Full Text] [Related]  

  • 25. Relationships of psychotomimetic to anti-serotonin potencies of congeners of lysergic acid diethylamide (LSD-25).
    ISBELL H; MINER EJ; LOGAN CR
    Psychopharmacologia; 1959; 1():20-8. PubMed ID: 14405872
    [No Abstract]   [Full Text] [Related]  

  • 26. [Synthesis of lysergic acid diethylamide (LSD)].
    Urakubo G; Hasegawa A; Kido Y
    Eisei Shikenjo Hokoku; 1970; 88():72-4. PubMed ID: 6015313
    [No Abstract]   [Full Text] [Related]  

  • 27. [Pharmacological trials concerning the mechanism of convulsions due to pure oxygen under pressure in mice].
    LABORIT H; BROUSSOLLE B; PERRIMOND-TROUCHET R
    J Physiol (Paris); 1957 Nov; 49(5):953-62. PubMed ID: 13514634
    [No Abstract]   [Full Text] [Related]  

  • 28. Chemotherapeutic trials in psychosis. III. 2-Brom-d-lysergic acid diethylamide (BOL 148).
    TURNER WJ; MERLIS S
    Am J Psychiatry; 1958 Feb; 114(8):751-2. PubMed ID: 13498199
    [No Abstract]   [Full Text] [Related]  

  • 29. [Psychopathological experiences with the combined action of lysergic acid mono- & diethylamide (LAE-32, LSD-25)].
    CALLIERI B; RAVETTA M
    Riv Sper Freniatr Med Leg Alien Ment; 1957 Jul; 81(2):267-313. PubMed ID: 13466954
    [No Abstract]   [Full Text] [Related]  

  • 30. [Chemical structure and lysergic acid derivative psychoses].
    SOLMS H
    Praxis; 1956 Aug; 45(32):746-9. PubMed ID: 13359249
    [No Abstract]   [Full Text] [Related]  

  • 31. [Peptide alkaloids of spurred rye and their semisynthetic derivatives. I. Chemistry of alkaloids (brief survey). II. Pharmacology of ergot].
    Mercier C
    J Pharm Belg; 1982; 37(3):219-27. PubMed ID: 7131229
    [No Abstract]   [Full Text] [Related]  

  • 32. [Effect of monoethylamide (LAE) and diethylamide (LSD) of lysergic acid on behavior of mouse with imino-beta, beta-dipropionitrile induced circular movement].
    WIDLOCHER D; NAKAJIMA H; THUILLIER J
    C R Seances Soc Biol Fil; 1957; 151(4):668-70. PubMed ID: 13489946
    [No Abstract]   [Full Text] [Related]  

  • 33. Caring for the "bad trip". A review of current status of LSD.
    Martin CM
    Hawaii Med J; 1970; 29(7):555-60. PubMed ID: 5490958
    [No Abstract]   [Full Text] [Related]  

  • 34. Studies on the in vitro metabolism of compounds related to lysergic acid diethylamide (LSD).
    Niwaguchi T; Inoue T; Sakai T
    Biochem Pharmacol; 1974 Nov; 23(21):3063-6. PubMed ID: 4429602
    [No Abstract]   [Full Text] [Related]  

  • 35. Chemotherapeutic trials in psychosis. III. Addendum-2-brom-d-lysergic acid diethylamide (BOL).
    TURNER WJ; ALMUDEVAR M; MERLIS S
    Am J Psychiatry; 1959 Sep; 116():261-2. PubMed ID: 13839967
    [No Abstract]   [Full Text] [Related]  

  • 36. [Psychoactive effects of 'legal high': About lysergic acid amide (LSA)].
    Ponté C; Lapeyre-Mestre M
    Therapie; 2017 Oct; 72(5):605-608. PubMed ID: 28457570
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The anti-tumor action of lysergic acid derivatives and their serotonin-blocking effect as reflected by the I 131 distribution in rats.
    SCOTT KG; STONE RS
    Cancer Res; 1959 Aug; 19():783-7. PubMed ID: 14444248
    [No Abstract]   [Full Text] [Related]  

  • 38. [Pharmacology of d-lysergic acid cycloalkylamides].
    VOTAVA Z
    J Physiol (Paris); 1957; 49(1):417-9. PubMed ID: 13449863
    [No Abstract]   [Full Text] [Related]  

  • 39. Pharmacology of d-lysergic acid morpholide (LSM).
    GOGERTY JH; DILLE JM
    J Pharmacol Exp Ther; 1957 Jul; 120(3):340-8. PubMed ID: 13476356
    [No Abstract]   [Full Text] [Related]  

  • 40. [Pharmacological properties of d-lysergic acid cycloalkylamides].
    VOTAVA Z; PODVALOVA I
    Cas Lek Cesk; 1958 Aug; 97(34):1062-6. PubMed ID: 13597011
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.